Detalhe da pesquisa
1.
Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
Clin Cancer Res
; 15(10): 3297-304, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19401348
2.
Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia.
Mod Pathol
; 22(1): 31-6, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18660794
3.
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
Int J Cancer
; 123(3): 569-76, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18478571
4.
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.
Cancer Res
; 64(5): 1632-8, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14996721
5.
Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer.
Oncogene
; 21(16): 2476-83, 2002 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-11971182
6.
Intratumor heterogeneity in hepatocellular carcinoma.
Clin Cancer Res
; 21(8): 1951-61, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25248380
7.
Morphologic and molecular characterization of renal cell carcinoma in children and young adults.
Am J Surg Pathol
; 28(9): 1117-32, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15316311
8.
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma.
J Pathol
; 196(2): 186-93, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11793370